DossiMed.ai VS Diffyn

DossiMed.ai's answer

DossiMed is the only personal health record that bundles AI prescription OCR, a truly multilingual experience (French, Arabic, English, Dutch — with Arabic RTL-first design), a multichannel medication-adherence escalation stack (push → WhatsApp → AI voice call), and a no-login doctor share link in a single app.

It turns paper prescriptions and lab reports into structured, queryable records, auto-generates a visual dosing calendar with real dosage-form icons (pill, half-pill, syrup, drops, inhaler, patch), and lets a whole family be managed in one secure vault. Doctors open a time-limited, read-only view by QR code or secure link — no account, no install. GDPR-by-design, hosted in Switzerland (Supabase eu-central-2).

Diffyn's answer:

Addresses workflow and change management on LLM prompts, provide teams with traceability and visualization of tests across multiple models, provide deeper understading into efficiency of these prompts.

DossiMed.ai's answer

Most alternatives solve only one slice of the problem. Medication apps like Medisafe and MyTherapy are US/EU-centric, manual, and have no Arabic, no AI OCR, and no document vault. National records (Mon Espace Santé, NHS App) are country-bound, with no AI structuring and no escalation reminders. Booking platforms (Doctolib, DabaDoc, Vezeeta) handle appointments, not a patient-owned record.

DossiMed is the only app that combines AI prescription structuring, Arabic RTL, WhatsApp + AI-voice reminder escalation, and a no-login doctor share link in one place — purpose-built for the people across Africa, MENA, and their diasporas who carry paper prescriptions and rely on WhatsApp. It also runs offline-first on low-cost Android devices. Free core tier; Premium from $2.99/month.

Diffyn's answer:

Diffyn is the platform that specializes on both change management and multi-model analysis.

DossiMed.ai's answer

• Flutter — offline-first cross-platform mobile app (Android and iOS)
• Supabase / PostgreSQL — hosted in Switzerland (eu-central-2, Zürich) for GDPR adequacy
• Azure Document Intelligence + GPT-4o — OCR and structuring of prescriptions, lab results, and imaging reports
• Serverless edge functions — the AI extraction pipeline, portable across AI providers
• WhatsApp Business API — medication reminder escalation
• AI voice-call integration — multilingual (French, Arabic, English) voice reminders
• Web doctor viewer (viewer.dossimed.ai) — read-only access via QR code or secure link, no app or account required

Diffyn's answer:

React, Next.js, POSTGRESQL

DossiMed.ai's answer

DossiMed serves two audiences.

Consumers: patients and families managing chronic conditions, elderly relatives, and children's treatments — across Francophone Europe, the Netherlands, Tunisia, the Maghreb, the broader MENA region, and African and diaspora communities. It is built especially for multilingual households that need French, Arabic, English, or Dutch in a single family vault, and for caregivers managing a relative's medication from afar.

Partners (B2B): health insurers, telecom operators, and pharmaceutical groups that want a production-grade, GDPR-by-design chronic-care platform to deploy white-label, license by territory or therapeutic area, or acquire as full IP.

Diffyn's answer:

Professionals incorporating LLMs or AI tools in their workflow and wants to keep track of changes and test their prompts.

DossiMed.ai's answer

DossiMed was built by REC SUARL, an export-oriented Tunisian software company, and founded by Yasmine Boudhina — an INSAT engineer with 13+ years in infrastructure and DevOps, a Microsoft Certified Trainer, and a top-3 alum of Founder Institute Middle East.

The idea came from a problem most Western health-tech overlooks: across Africa, the Arab world, and their diasporas, the majority of prescriptions are still handwritten or printed on paper, there is no national patient record, and families coordinate care over WhatsApp. People lose prescriptions, miss doses, and arrive at appointments with no history.

DossiMed was created to give those patients a record that is always with them — multilingual (French, Arabic, English, Dutch), AI-structured, and shareable with any doctor in seconds. It is production-grade, GDPR-by-design, and hosted in Switzerland.

Diffyn's answer:

I started working on Diffyn when I notice that prompting has become an essential part of work across many industries. While there are version control platofrms like github, they are not designed for just prompt management are can be overkill such applications, it is also not integrated natively with various LLMs and relevant tools for users to validate ideas and visualise results properly.

DossiMed.ai's answer

DossiMed is in its market-entry and partnership phase and does not yet publicly disclose named customers. The consumer app is live on Google Play for patients and families, and these are the enterprise segments DossiMed engages for white-label, licensing, and IP-transfer deployments:

• Health insurers (member medication-adherence and chronic-care programs)
• Telecom operators (health value-added services for subscribers)
• Pharmaceutical groups (patient-support and adherence programs)
• Public-health bodies and NGOs across MENA and Africa

Partnership inquiries: https://dossimed.ai/en/partnerships